Michael J. Sofia - Net Worth and Insider Trading

Michael J. Sofia Net Worth

The estimated net worth of Michael J. Sofia is at least $7 Million dollars as of 2024-11-05. Michael J. Sofia is the Chief Scientific Officer of Arbutus Biopharma Corp and owns about 1,652,283 shares of Arbutus Biopharma Corp (ABUS) stock worth over $7 Million. Details can be seen in Michael J. Sofia's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael J. Sofia has not made any transactions after 2024-02-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael J. Sofia

To

Michael J. Sofia Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael J. Sofia owns 1 companies in total, including Arbutus Biopharma Corp (ABUS) .

Click here to see the complete history of Michael J. Sofia’s form 4 insider trades.

Insider Ownership Summary of Michael J. Sofia

Ticker Comapny Transaction Date Type of Owner
ABUS Arbutus Biopharma Corp 2024-02-02 Chief Scientific Officer

Michael J. Sofia Latest Holdings Summary

Michael J. Sofia currently owns a total of 1 stock. Michael J. Sofia owns 1,652,283 shares of Arbutus Biopharma Corp (ABUS) as of February 2, 2024, with a value of $7 Million.

Latest Holdings of Michael J. Sofia

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABUS Arbutus Biopharma Corp 2024-02-02 1,652,283 3.95 6,518,256

Holding Weightings of Michael J. Sofia


Michael J. Sofia Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael J. Sofia has made a total of 2 transactions in Arbutus Biopharma Corp (ABUS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Arbutus Biopharma Corp is the sale of 9,982 shares on February 2, 2024, which brought Michael J. Sofia around $23,058.

Insider Trading History of Michael J. Sofia

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael J. Sofia Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael J. Sofia Ownership Network

Ownership Network List of Michael J. Sofia

No Data

Ownership Network Relation of Michael J. Sofia

Insider Network Chart

Michael J. Sofia Owned Company Details

What does Arbutus Biopharma Corp do?

Who are the key executives at Arbutus Biopharma Corp?

Michael J. Sofia is the Chief Scientific Officer of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Medical Officer Karen Sims .

Arbutus Biopharma Corp (ABUS) Insider Trades Summary

Over the past 18 months, Michael J. Sofia made 1 insider transaction in Arbutus Biopharma Corp (ABUS) with a net sale of 9,982. Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,593 shares made by David C Hastings , and a net sale of 8,846 shares made by Keith S Manchester .

In summary, during the past 3 months, insiders sold 8,846 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 8,846 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.

Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arbutus Biopharma Corp Insider Transactions

No Available Data

Michael J. Sofia Mailing Address

Above is the net worth, insider trading, and ownership report for Michael J. Sofia. You might contact Michael J. Sofia via mailing address: C/o Arbutus Biopharma Corp., Suite 100, 8900 Glenlyon Parkway, Burnaby A1 V5j 5j8.